Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (1011-1020 of 1,212) with videos related to

Pageof 122
Sort By:
Journal of the American Heart Association|August 27, 2015
Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical TrialPierluigi Tricoci, Denise M D'Andrea, Paul A Gurbel, et al.
JAMA Surgery|July 31, 2014
Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trialRalf E Harskamp, John H Alexander, Phillip J Schulte, et al.
Annals of Surgery|December 26, 2013
Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgerySean van Diepen, J Matthew Brennan, Gail E Hafley, et al.
The Annals of Thoracic Surgery|January 29, 2008
Impact of saphenous vein graft radiographic markers on clinical events and angiographic parametersStephen A Olenchock, Dimitri Karmpaliotis, William J Gibson, et al.
Diabetology International|March 25, 2020
Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA<sup>®</sup> trialNobuya Inagaki, Wenying Yang, Hirotaka Watada, et al.
Circulation|February 19, 2019
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body WeightStefan H Hohnloser, Marat Fudim, John H Alexander, et al.
European Heart Journal|September 16, 2015
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trialDragos Vinereanu, Susanna R Stevens, John H Alexander, et al.
American Heart Journal|February 16, 2018
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trialMatthew W Sherwood, Renato D Lopes, Jie Lena Sun, et al.
Pharmacological Reviews|May 21, 2013
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsAnthony P Davenport, Stephen P H Alexander, Joanna L Sharman, et al.
Journal of the American College of Cardiology|March 19, 2025
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial FibrillationLars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.
Pageof 122

Showing results (1011-1020 of 1,212) with videos related to

Sort By:
Pageof 122
Journal of the American Heart Association|August 27, 2015
Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical TrialPierluigi Tricoci, Denise M D'Andrea, Paul A Gurbel, et al.
JAMA Surgery|July 31, 2014
Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trialRalf E Harskamp, John H Alexander, Phillip J Schulte, et al.
Annals of Surgery|December 26, 2013
Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgerySean van Diepen, J Matthew Brennan, Gail E Hafley, et al.
The Annals of Thoracic Surgery|January 29, 2008
Impact of saphenous vein graft radiographic markers on clinical events and angiographic parametersStephen A Olenchock, Dimitri Karmpaliotis, William J Gibson, et al.
Diabetology International|March 25, 2020
Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA<sup>®</sup> trialNobuya Inagaki, Wenying Yang, Hirotaka Watada, et al.
Circulation|February 19, 2019
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body WeightStefan H Hohnloser, Marat Fudim, John H Alexander, et al.
European Heart Journal|September 16, 2015
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trialDragos Vinereanu, Susanna R Stevens, John H Alexander, et al.
American Heart Journal|February 16, 2018
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trialMatthew W Sherwood, Renato D Lopes, Jie Lena Sun, et al.
Pharmacological Reviews|May 21, 2013
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsAnthony P Davenport, Stephen P H Alexander, Joanna L Sharman, et al.
Journal of the American College of Cardiology|March 19, 2025
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial FibrillationLars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.
Pageof 122